Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Acute prazosin administration does not reduce stressor reactivity in healthy adults
by
Fronk, Gaylen E
, Curtin, John J
, Cruz, Maireni R
, Zgierska, Aleksandra E
, Kaye, Jesse T
, Rabago, David
in
Alcohol use
/ Antagonists
/ Anxiety
/ Clinical trials
/ Laboratories
/ Mental disorders
/ Nervous system
/ Neurosciences
/ Norepinephrine
/ Population studies
/ Post traumatic stress disorder
/ Potentiation
/ Prazosin
/ Stress
/ Stress response
2019
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Acute prazosin administration does not reduce stressor reactivity in healthy adults
by
Fronk, Gaylen E
, Curtin, John J
, Cruz, Maireni R
, Zgierska, Aleksandra E
, Kaye, Jesse T
, Rabago, David
in
Alcohol use
/ Antagonists
/ Anxiety
/ Clinical trials
/ Laboratories
/ Mental disorders
/ Nervous system
/ Neurosciences
/ Norepinephrine
/ Population studies
/ Post traumatic stress disorder
/ Potentiation
/ Prazosin
/ Stress
/ Stress response
2019
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Acute prazosin administration does not reduce stressor reactivity in healthy adults
by
Fronk, Gaylen E
, Curtin, John J
, Cruz, Maireni R
, Zgierska, Aleksandra E
, Kaye, Jesse T
, Rabago, David
in
Alcohol use
/ Antagonists
/ Anxiety
/ Clinical trials
/ Laboratories
/ Mental disorders
/ Nervous system
/ Neurosciences
/ Norepinephrine
/ Population studies
/ Post traumatic stress disorder
/ Potentiation
/ Prazosin
/ Stress
/ Stress response
2019
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Acute prazosin administration does not reduce stressor reactivity in healthy adults
Journal Article
Acute prazosin administration does not reduce stressor reactivity in healthy adults
2019
Request Book From Autostore
and Choose the Collection Method
Overview
RationaleNorepinephrine plays a critical role in the stress response. Clarifying the psychopharmacological effects of norepinephrine manipulation on stress reactivity in humans has important implications for basic neuroscience and treatment of stress-related psychiatric disorders, such as posttraumatic stress disorder and alcohol use disorders. Preclinical research implicates the norepinephrine alpha-1 receptor in responses to stressors. The No Shock, Predictable Shock, Unpredictable Shock (NPU) task is a human laboratory paradigm that is well positioned to test cross-species neurobiological stress mechanisms and advance experimental therapeutic approaches to clinical trials testing novel treatments for psychiatric disorders.ObjectivesWe hypothesized that acute administration of prazosin, a noradrenergic alpha-1 antagonist, would have a larger effect on reducing stress reactivity during unpredictable, compared to predictable, stressors in the NPU task.MethodsWe conducted a double-blind, placebo-controlled, crossover randomized controlled trial in which 64 healthy adults (32 female) completed the NPU task at two visits (2 mg prazosin vs. placebo).ResultsA single acute dose of 2 mg prazosin did not reduce stress reactivity in a healthy adult sample. Neither NPU startle potentiation nor self-reported anxiety was reduced by prazosin (vs. placebo) during unpredictable (vs. predictable) stressors.ConclusionsFurther research is needed to determine whether this failure to translate preclinical neuroscience to human laboratory models is due to methodological factors (e.g., acute vs. chronic drug administration, brain penetration, study population) and/or suggests limited clinical utility of noradrenergic alpha-1 antagonists for treating stress-related psychiatric disorders.
Publisher
Springer Nature B.V
This website uses cookies to ensure you get the best experience on our website.